Background: Sucralose is a unique disaccharide probe which is stable in the colon and can be used to assess permeability over the whole gut. Additional information can be gained when sucralose is administered in combination with lactulose and a monosaccharide such as L-rhamnose in the form of a 'triple sugar test.' We describe a simple assay for urinary sucralose by HPLC with refractive index detection (HPLC-RI).
Introduction
Tests of intestinal permeability rely on quantifying urinary excretion of orally administered disaccharides such as lactulose, often in combination with a monosaccharide such as mannitol or L-rhamnose. 1 Conventional sugar probes undergo colonic fermentation and can only be used to assess small intestinal permeability.
Sucralose is an arti¢cial sweetener formed by the chlorination of sucrose. In recent years, sucralose has been used as an intestinal permeability probe in both human and animal studies. 2--4 Unlike lactulose and other disaccharides, sucralose is not fermented by the action of gastrointestinal bacteria and can therefore be used as a measure of whole gut permeability.When administered as a'triple sugar test' in combination with lactulose and a monosaccharide such as L-rhamnose or mannitol, sucralose may theoretically be used to estimate colonic permeability. 4 A number of analytical methods have been used to quantify sucralose in food and body £uids, including gas chromatography, capillary electrophoresis, C 14 radiolabelling and HPLC with ultraviolet, mass spectrometry and amperometric detection. Many of these techniques are time-consuming, technically challenging or otherwise inappropriate for use in clinical studies. We describe a simple technique of HPLC with refractive index detection (HPLC-RI) which has been successfully employed in clinical studies of intestinal permeability in the authors' institution. 4
Methods

Sample preparation
A series of standards were prepared by adding analytical-grade micronized sucralose (McNeil Nutritionals, NJ, USA) to urine collected from 60 randomly selected hospitalized patients. Rapid sample preparation was achieved by adding 100 mL of internal standard (analytical-grade phenyl-b-D-glucopyranoside, 10 mg/mL, Fluka) to 10 mL of urine, which was then passed through a 0.45 mm (pore size) ¢lter (Alltech Associates, Carnforth, UK).
HPLC analysis
In all, 100 mL of the ¢ltrate was injected onto a 250 Â 4.6 mm Luna C18(2) reverse-phase column (Phenomenex, Torrance, CA, USA) and eluted with 30% methanol in water at a £ow rate of 1mL/min. Detection was with a Gilson 133 refractive index detector (Gilson, Middleton, WI, USA). Data from the detector were routed to a data collection unit (PL-DCU; Polymer Laboratories, Amherst, MA, USA) and integration performed using Polymer Laboratories software PL LC/GC Version 2.0. Quanti¢cation was by peak area, with internal standardization. All runs were duplicated and mean peak area used to calculate concentration. Figure 1 shows chromatograms of untreated urine and urine after the addition of sucralose (50 mg/L) and internal standard. Both sucralose and the internal standard were well resolved within 15 min. In four of 60 urine samples the internal standard peak was poorly resolved from unidenti¢ed urinary components. Quanti¢cation of sucralose in these instances was based on sucralose peak area alone.
Results
The standard curve for sucralose was linear from 25 to 500 mg/L (r40.99). The limit of detection, assessed by a signal to noise ratio of 3:1, was 11mg/L. Analytical recovery of sucralose at concentrations of 25, 50 and 100 mg/L was 101.5% (CV 7.59%), 102.9% (CV 5.82%) and 105.0% (CV 4.26%) respectively (n ¼ 20 for each concentration). Overall recovery was 103.1% (CV 6.07%).
Conclusions
The HPLC-RI method described above was simple to perform and had acceptable accuracy and precision for use in clinical studies of intestinal permeability. With rapid sample preparation combined with a short analysis time, this technique is practicable in a hospital laboratory; the use of an automated injector would further extend capability.
The relative insensitivity of the method (limit of detection 11mg/L) when compared with HPLC with pulsed electrochemical detection (HPLC-PED) is a disadvantage. However, HPLC-PED is a less robust technique and requires greater expertise to gain satisfactory results. 5 In fact, following oral administration, published rates of urinary sucralose excretion approximate 2% over 24 h; 3, 4 therefore the sensitivity of the HPLC-RI was quite adequate to quantify sucralose excretion following an oral test dose of 5 g (anticipated urinary concentration of the order of 50 mg/L, assuming a 24 h urine volume of 2000 mL).
It is hoped that the introduction of this simple technique for quantifying urinary sucralose will broaden the scope of the triple sugar test as a clinical research tool. 
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